TSA is a parent-led registered charity for an ultra-rare genetic disease which presents with a spectrum of cardiovascular, endocrine and neurological/ neurodevelopmental symptoms.
Our mission focuses on improving diagnosis rates, treatment, and support for individuals with CACNA1C-related disorders which includes Timothy Syndrome and LongQT8, while also aiding their families and caregivers. We focus on five core areas: raising awareness and understanding, improving diagnosis and care, supporting our community, providing information and advice, and driving research and clinical development. By prioritising these vital areas, we aim to make a lasting impact.
We align with the following UN Sustainable Development Goals:
